Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2020 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial.
Zieliński M, Żalińska M, Iwaszkiewicz-Grześ D, Gliwiński M, Hennig M, Jaźwińska-Curyłło A, Kamińska H, Sakowska J, Wołoszyn-Durkiewicz A, Owczuk R, Młynarski W, Jarosz-Chobot P, Bossowski A, Szadkowska A, Siebert J, Myśliwiec M, Marek-Trzonkowska N, Trzonkowski P. Zieliński M, et al. Among authors: zalinska m. Diabetes Obes Metab. 2022 Aug;24(8):1534-1543. doi: 10.1111/dom.14723. Epub 2022 May 9. Diabetes Obes Metab. 2022. PMID: 35441440 Clinical Trial.
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
Gliwiński M, Iwaszkiewicz-Grześ D, Wołoszyn-Durkiewicz A, Tarnowska M, Żalińska M, Hennig M, Zielińska H, Dukat-Mazurek A, Zielkowska-Dębska J, Zieliński M, Jaźwińska-Curyłło A, Owczuk R, Jarosz-Chobot P, Bossowski A, Szadkowska A, Młynarski W, Marek-Trzonkowska N, Moszkowska G, Siebert J, Myśliwiec M, Trzonkowski P. Gliwiński M, et al. Among authors: zalinska m. BMJ Open Diabetes Res Care. 2020 Feb;8(1):e000873. doi: 10.1136/bmjdrc-2019-000873. BMJ Open Diabetes Res Care. 2020. PMID: 32098895 Free PMC article.
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
Marek-Trzonkowska N, Myśliwiec M, Iwaszkiewicz-Grześ D, Gliwiński M, Derkowska I, Żalińska M, Zieliński M, Grabowska M, Zielińska H, Piekarska K, Jaźwińska-Curyłło A, Owczuk R, Szadkowska A, Wyka K, Witkowski P, Młynarski W, Jarosz-Chobot P, Bossowski A, Siebert J, Trzonkowski P. Marek-Trzonkowska N, et al. Among authors: zalinska m. J Transl Med. 2016 Dec 1;14(1):332. doi: 10.1186/s12967-016-1090-7. J Transl Med. 2016. PMID: 27903296 Free PMC article. Clinical Trial.
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration.
Zieliński M, Sakowska J, Iwaszkiewicz-Grześ D, Gliwiński M, Hennig M, Żalińska M, Wołoszyn-Durkiewicz A, Jaźwińska-Curyłło A, Kamińska H, Owczuk R, Młynarski W, Jarosz-Chobot P, Bossowski A, Szadkowska A, Fendler W, Beń-Skowronek I, Chobot A, Myśliwiec M, Siebert J, Marek-Trzonkowska N, Trzonkowski P. Zieliński M, et al. Among authors: zalinska m. Int Immunopharmacol. 2024 Mar 29;132:111919. doi: 10.1016/j.intimp.2024.111919. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38554443
Assessing the knowledge of the consequences of uncontrolled diabetesin pregnancy and its effects on fetal development, among femaleadolescents with type 1 diabetes.
Wołoszyn-Durkiewicz A, Żalińska M, Brandt A, Myśliwiec M, Ściesińska M, Kuhn J. Wołoszyn-Durkiewicz A, et al. Among authors: zalinska m. Pediatr Endocrinol Diabetes Metab. 2017;23(4):188-196. doi: 10.18544/PEDM-23.04.0092. Pediatr Endocrinol Diabetes Metab. 2017. PMID: 29574471 Free article.